FDA Recall: Ranitidine Products

| 03/04/2020 | 0 Comments

The FDA has ordered a recall of all Ranitidine products, due to manufacturing issues. Patients taking any form of prescription Ranitidine (tablets or liquids) have been asked to discontinue and contact their doctor for an alternative. Persons have also been advised not to purchase over-the-counter Ranitidine products (e.g. Zantac®).

Tags: ,

Category: Local News

You can comment anonymously. Please read the CNS Comment Policy at the top of this page.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Please support independent journalism in the Cayman Islands